172 related articles for article (PubMed ID: 21435101)
1. Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.
Kitamura A; Matsushita K; Takiguchi Y; Shimada H; Tada Y; Yamanaka M; Hiroshima K; Tagawa M; Tomonaga T; Matsubara H; Inoue M; Hasegawa M; Sato Y; Levens D; Tatsumi K; Nomura F
Cancer Sci; 2011 Jul; 102(7):1366-73. PubMed ID: 21435101
[TBL] [Abstract][Full Text] [Related]
2. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.
Matsushita K; Shimada H; Ueda Y; Inoue M; Hasegawa M; Tomonaga T; Matsubara H; Nomura F
World J Gastroenterol; 2014 Apr; 20(15):4316-28. PubMed ID: 24764668
[TBL] [Abstract][Full Text] [Related]
3. Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer.
Tanaka N; Araki K; Mizokami D; Miyagawa Y; Yamashita T; Tomifuji M; Ueda Y; Inoue M; Matsushita K; Nomura F; Shimada H; Shiotani A
Gene Ther; 2015 Apr; 22(4):297-304. PubMed ID: 25588744
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosis.
Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Ueda Y; Shimada H; Matsushita K; Shiotani A
PLoS One; 2015; 10(1):e0116279. PubMed ID: 25569246
[TBL] [Abstract][Full Text] [Related]
5. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
[TBL] [Abstract][Full Text] [Related]
6. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
Inoue H; Iga M; Nabeta H; Yokoo T; Suehiro Y; Okano S; Inoue M; Kinoh H; Katagiri T; Takayama K; Yonemitsu Y; Hasegawa M; Nakamura Y; Nakanishi Y; Tani K
Cancer Sci; 2008 Nov; 99(11):2315-26. PubMed ID: 18957055
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties.
Inoue M; Tokusumi Y; Ban H; Shirakura M; Kanaya T; Yoshizaki M; Hironaka T; Nagai Y; Iida A; Hasegawa M
J Gene Med; 2004 Oct; 6(10):1069-81. PubMed ID: 15386740
[TBL] [Abstract][Full Text] [Related]
8. BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression.
Morodomi Y; Yano T; Kinoh H; Harada Y; Saito S; Kyuragi R; Yoshida K; Onimaru M; Shoji F; Yoshida T; Ito K; Shikada Y; Maruyama R; Hasegawa M; Maehara Y; Yonemitsu Y
Mol Ther; 2012 Apr; 20(4):769-77. PubMed ID: 22314292
[TBL] [Abstract][Full Text] [Related]
9. An orthotopic implantation mouse model of human malignant pleural mesothelioma for in vivo photon counting analysis and evaluation of the effect of S-1 therapy.
Yanagihara K; Tsumuraya M; Takigahira M; Mihara K; Kubo T; Ohuchi K; Seyama T
Int J Cancer; 2010 Jun; 126(12):2835-46. PubMed ID: 19876922
[TBL] [Abstract][Full Text] [Related]
10. Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins.
Inoue M; Tokusumi Y; Ban H; Kanaya T; Tokusumi T; Nagai Y; Iida A; Hasegawa M
J Virol; 2003 Mar; 77(5):3238-46. PubMed ID: 12584347
[TBL] [Abstract][Full Text] [Related]
11. Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein.
Ban H; Inoue M; Griesenbach U; Munkonge F; Chan M; Iida A; Alton EW; Hasegawa M
Gene Ther; 2007 Dec; 14(24):1688-94. PubMed ID: 17898794
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma.
Adusumilli PS; Chan MK; Chun YS; Hezel M; Chou TC; Rusch VW; Fong Y
Cancer Biol Ther; 2006 Jan; 5(1):48-53. PubMed ID: 16294031
[TBL] [Abstract][Full Text] [Related]
13. Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma.
Silberhumer GR; Brader P; Wong J; Serganova IS; Gönen M; Gonzalez SJ; Blasberg R; Zamarin D; Fong Y
Mol Cancer Ther; 2010 Oct; 9(10):2761-9. PubMed ID: 20858727
[TBL] [Abstract][Full Text] [Related]
14. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
Zanellato I; Colangelo D; Osella D
Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
[TBL] [Abstract][Full Text] [Related]
15. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
Onen HI; Yilmaz A; Alp E; Celik A; Demiroz SM; Konac E; Kurul IC; Menevse ES
Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
[TBL] [Abstract][Full Text] [Related]
16. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo.
Ferrari S; Griesenbach U; Shiraki-Iida T; Shu T; Hironaka T; Hou X; Williams J; Zhu J; Jeffery PK; Geddes DM; Hasegawa M; Alton EW
Gene Ther; 2004 Nov; 11(22):1659-64. PubMed ID: 15284837
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.
Kano M; Matsushita K; Rahmutulla B; Yamada S; Shimada H; Kubo S; Hiwasa T; Matsubara H; Nomura F
Gene Ther; 2016 Jan; 23(1):50-6. PubMed ID: 26241176
[TBL] [Abstract][Full Text] [Related]
18. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.
Adusumilli PS; Stiles BM; Chan MK; Mullerad M; Eisenberg DP; Ben-Porat L; Huq R; Rusch VW; Fong Y
J Gene Med; 2006 May; 8(5):603-15. PubMed ID: 16475242
[TBL] [Abstract][Full Text] [Related]
19. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
[TBL] [Abstract][Full Text] [Related]
20. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M
J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
